The invention concerns a 2',2'-difluoro-2'-deoxycytidine derivative of general formula (I), wherein: R1, R2 and R3, identical or different, represent independently of one another, a hydrogen atom or an at least C18 hydrocarbon acyl radical and of such conformation that it is capable of providing said compound of general formula (I), a compacted form in a polar solvent medium, at least one of groups R1, R2 and R3 being other than a hydrogen atom.

Gemcitabine derivatives nanoparticles

STELLA, Barbara;CATTEL, Luigi;ROCCO, Flavio;
2006

Abstract

The invention concerns a 2',2'-difluoro-2'-deoxycytidine derivative of general formula (I), wherein: R1, R2 and R3, identical or different, represent independently of one another, a hydrogen atom or an at least C18 hydrocarbon acyl radical and of such conformation that it is capable of providing said compound of general formula (I), a compacted form in a polar solvent medium, at least one of groups R1, R2 and R3 being other than a hydrogen atom.
WO2006090029 (A1)
CENTRE NAT RECH SCIENT; UNIV PARIS SUD; ROCCO FLAVIO
Gemcitabine; nanoparticles; anticancer agents; antiviral agents
STELLA B; CATTEL L; ROCCO F; COUVREUR P; RENOIR JM; ROSILIO V
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/51912
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact